Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: Case report and review of the literature

Clinical Neuropathology

Volumn 26, Issue 2, 2007, Pages 68-73

  Freim Wahl, S G ^a   Folvik, M R ^a   Torp, S H ^a  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

Author keywords

B cell lymphoma; Immunosuppression; Infection; JC virus; Progressive multifocal leukoencephalopathy (PML); Rituximab

Indexed keywords

ANTIRETROVIRUS AGENT; CARISOPRODOL; CHLORAMBUCIL; CHLORPROTHIXENE; CYTARABINE; CYTOSTATIC AGENT; DEXAMETHASONE; DIAZEPAM; DOXORUBICIN; ETOPOSIDE; FLUNITRAZEPAM; MITOXANTRONE; NUCLEOSIDE ANALOG; PREDNISOLONE; PREDNISONE; PROCARBAZINE; RITUXIMAB; SEROTONIN ANTAGONIST; TRAMADOL; VINCRISTINE;

ADULT; ANXIETY DISORDER; ARTICLE; BRONCHOPNEUMONIA; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER STAGING; CASE REPORT; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEMYELINATING DISEASE; DEPRESSION; DRUG MEGADOSE; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; JC VIRUS; LYMPHOMA; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RADIATION DOSE; TREATMENT RESPONSE;

EID: 33947106025     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/npp26068     Document Type: Article

References (25)

1. Aström K-E, Mancall EL, Richardson EP jr. Progressive multifocal leukoencephalopathy. A hitherto unrecognized complication of chronic lymphatic leukemia and Hodgkin's disease. Brain. 1958; 81: 93-111.
2. Baqi M, Kucharczyk W, Walmsley SL. Regression of progressive multifocal leukoencephalopathy with highly active antiretroviral therapy. AIDS. 1997; 11: 1526-1527.
3. Berger JR, Levy RM, Flomenhoft D, Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol. 1998; 44: 341-349.
4. Bjerrum OW, Hansen OE. Progressive multifocal leukoencephalopathy in Hodgkin's disease. Scand J Hematol. 1985; 34: 442-445.
5. Chesters PM, Heritage J, McCance DJ. Persistence of DNA sequences of BK virus and JC virus in normal human tissues and in diseased tissues. J Infect Dis. 1983; 147: 676-684.
6. Clifford DB. Challenges for clinical trials to treat progressive multifocal leukoencephalopathy. J Neurovirol. 2003; 9 (Suppl 1): 68-72.
7. Domingo P, Guardiola JM, Iranzo A, Margall N. Remission of progressive multifocal leukoencephalopathy after antiretroviral therapy. Lancet. 1997; 349: 1554-1555.
8. Elphick GF, Querbes W, Jordan JA et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science. 2004; 306: 1380-1383.
9. García-Suãrez J, de Miguel D, Krsnik I, Banas H, Arribas I, Burgaleta C. Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of noval therapies. Am J Hematol. 2005; 80: 271-281.
10. Goldberg SL, Pecora AL, Alter RS, Kroll MS, Rowley SD, Waintraub SE, Imrit K, Preti RA. Unusual viral infections (progressive multifocal leukoencephalopathy and cytomegalovirus disease) after high-dose chemotherapy with autologous blood stem cell rescue and peritransplantation rituximab. Blood. 2002; 99: 1486-1488.
11. Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W. Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med. 1988; 318: 301-305.
12. Matteucci P, Magni M, Di Nicola M, Carlo-Stella C, Uberti C, Gianni AM. Leukoencephalopathy and papovavirus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody. Blood. 2002; 100: 1104-1105.
13. Monaco MCG, Atwood WJ, Gravell M, Tomatore CS, Major EO. JC virus infection of hematopoietic progenitor cells, primary B lymphocytes and tonsillar stromal cells: implications for viral latency. J Virol. 1996; 70: 7004-7012.
14. Padgett BL, Walker DL. Prevalence of antibodies in human sera against JC virus, an isolate from a case of progressive multifocal leukoencephalopathy. J Infect Dis. 1973; 27: 467-470.
15. Padgett BL, Walker DL, ZuRhein GM, Eckroade RJ, Dessel BH. Cultivation of papova-like virus from human brain with progressive multifocal leukoencephalopathy. Lancet. 1971; 1: 1257-1260.
16. Pfister LA, Letvin NL, Koralnik IJ. JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy. J Virol. 2001; 75: 5672-5676.
17. Plosker GL, Figgitt DP. Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia. Drugs. 2003; 63: 803-843.
18. Sabath BF, Major EO. Traffic of JC virus from sites of initial infection to the brain: the path to progressive multifocal leukoencephalopathy. J Infect Dis. 2002; 186 (Suppl 2): S180-186.
19. Sharma VR, Fleming DR, Slone SP. Pure red cell aplasia due to parvovirus B19 in a patient treated with rituximab. Blood. 2000; 3: 1184-1186.
20. Song KW, Mollee P, Patterson B, Brien W, Crump M. Pure red cell aplasia due to parvovirus following treatment with CHOP and rituximab for B cell lymphoma. Br J Haematol. 2002; 119: 125-127.
21. Steingrimsdottir H, Gruber A, Bjorkholm M, Svensson A, Hansson M. Immune reconstitution after autologues stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Haematologica. 2000; 85: 832-838.
22. Steurer M, Clausen J. Progressive multifocal leukoencephalopathy after allogeneic stem cell transplantation and posttransplantation rituximab. Transplantation. 2003; 76: 435-436.
23. Tornatore C, Amemiya K, Atwood W, Conant K, Major EO. JC virus: current concepts and controversies in the molecular virology and pathogenesis of progressive multifocal leukoencephalopathy. Rev Med Virol. 1994; 4: 197-219.
24. Weber F, Goldmann L, Krämer M, Kaup FJ, Pichardt M, Young P, Petry H, Weber T, Lüke W. Cellular and humoral response in progressive multifocal leukoencephalopathy. Ann Neurol. 2001; 49: 636-642.
25. Wijermans PW, Gerrits WB, Haak HL. Severe immunodeficiency in patients treated with fludarabine monophosphate. Eur J Haematol 1993; 50: 292-296